Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a Phase I/IIa clinical trial evaluating the safety, tolerability, and preliminaryefficacy of human umbilical cord mesenchymal stem cell injection in patients with type 2DN. Phase I is a single‐center, prospective, open‐label, self‐controlled study toevaluate the safety and tolerability of MSCs and determine the recommended Phase II dose(RP2D). Phase IIa is a randomized, open‐label, standard treatment‐controlled study topreliminarily evaluate efficacy.
Epistemonikos ID: 6e580c65124eccae137e0ae1d65298326604d594
First added on: Aug 19, 2026